Survey shows GLP-1 weight-loss drugs are changing sex and dating for 50–60% of users
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S. adults (ages 18 to 91) led by the Kinsey Institute at Indiana University with DatingNews.com, GLP-1 ...
43 minutes ago
0
0
Antibiotic resistance predicts higher mortality risk in 17-year follow-up—linked to diet and gender
A population-based study led by the University of Turku, Finland, investigated factors associated with the prevalence of antibiotic resistance. In addition to antibiotic use, diet, gender, living environment, income level ...
Jul 15, 2025
0
0
FDA approves Kerendia for heart failure with ejection fraction of 40% or higher
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.
Jul 15, 2025
0
0
Clinical trial shows taking blood pressure medication at night improves nocturnal and daytime control
Research led by Sichuan University in China has revealed that bedtime antihypertensive medication dosing improves nocturnal blood pressure control over morning dosing in patients with hypertension.
Anti-nausea medication linked to higher survival rates in women with triple negative breast cancer
A new study has found that a commonly prescribed anti-nausea medication is associated with a better prognosis for women with early-stage breast cancer, particularly triple-negative breast cancer.
Jul 14, 2025
0
78
Anti-obesity medications can normalize testosterone levels in men
Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society's ...
Jul 14, 2025
0
0
Multi-component strategies for cholesterol control beyond adherence
Pharmacy researchers at the National University of Singapore (NUS) have demonstrated that multi-component interventions are required to improve the regular intake of cholesterol-lowering medications.
Jul 14, 2025
0
0
Weekly injection offers steady Parkinson's medication, reducing need for daily pills
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.
Jul 11, 2025
0
10
FDA publishes full texts of response letters to drug applications
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted to the agency from 2020 to 2024.
Jul 11, 2025
0
0
An FDA-approved drug halts Epstein-Barr virus-driven lymphoma by disrupting a key cancer pathway
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, published in the Journal ...
Jul 10, 2025
0
26
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks of developing dementia and mild cognitive impairment (MCI)—29% and 85%, respectively—finds ...
Jul 10, 2025
0
316
Prescription weight-loss medication linked to disordered eating behaviors in boys and men
As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research raises important concerns about their use among adolescent boys and young men.
Jul 10, 2025
0
0
Cannabinoid products may reduce total sleep time in adults with insomnia says new study
You might have heard cannabis and cannabinoid products can help people sleep. Data shows one of the top reasons people use cannabis is to help them sleep.
Jul 10, 2025
0
1
Does Australia really take too long to approve medicines, as the US says?
Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.
Jul 10, 2025
0
0
Largest review of antidepressants to date finds most people do not experience severe withdrawal
The largest review of "gold standard" antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience ...
Jul 9, 2025
0
71
Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to replace this current cornerstone in the treatment of drug-resistant ...
Jul 9, 2025
0
21
New compound shows promise in preventing premature births in mice
After nearly 15 years' research, scientists at the UdeM-affiliated CHU Sainte-Justine have developed a compound that has shown remarkable potential in preventing prematurity in mice.
Jul 9, 2025
0
0
Which factors affect the success of popular prescription weight loss drugs in individuals?
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss after taking prescription drugs called glucagon-like peptide-1 receptor agonists (GLP-1RAs), such ...
Jul 9, 2025
0
0
Poorer countries granted access to HIV prevention drug
Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.
Jul 9, 2025
0
0
'Dimmer switch' drug candidates offer hope for safer nerve pain and ischemic disease treatments
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ischemia-reperfusion injury.
Jul 8, 2025
0
11
First infant malaria treatment receives approval: Novartis
The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said Tuesday.
Jul 8, 2025
0
0
NRTI use linked to risk for primary open-angle glaucoma
Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.
Jul 8, 2025
0
0
Disparities exist in outpatient referrals for opioid use disorder, study finds
Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), according to a study published online in JAMA Network Open.
Jul 8, 2025
0
0
